Author: oncologs.com

When a cancer cell doesn’t respond to traditional therapies, doctors may turn to a sort of viral biological warfare, by deploying ‘troops’ in the form of viral agents that are specifically engineered to target and eliminate cancer cells. The mode of attack is to transform

LOS ANGELES — Physician scientists from City of Hope, one of the largest cancer research and treatment organizations in the United States, found that people with metastatic kidney cancer who orally took a live biotherapeutic product called CBM588 while in treatment with immunotherapy and enzymatic

LA JOLLA, CA—What happens when measles virus meets a human cell? The viral machinery unfolds in just the right way to reveal key pieces that let it fuse itself into the host cell membrane. Credit: Dawid Zyla, LJI LA JOLLA, CA—What happens when measles virus

Cracow, 26 June 2024 – Gold particles having the size of billionths of a metre are lethal to cancer cells. This fact has been known for a long time, as has a simple correlation: the smaller the nanoparticles used to fight the cancer cells, the faster they

Led by Rice’s Gang Bao and MD Anderson’s Dr. Jeffrey Molldrem, the initiative aims to foster collaboration between the two institutions on fundamental and translational cancer research, to develop new technologies for cancer detection and therapy and to secure external funding in support of further research

HOUSTON ― Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with unresectable, locally advanced non-small cell lung cancer (NSCLC).

Can artificial intelligence be used to help detect breast cancer? The answer is an unequivocal ‘yes’ according to a new study from the University of Copenhagen’s Department of Computer Science and the Capital Region of Denmark’s breast cancer screening programme. Credit: Photo: Department of Breast

HOUSTON ― The University of Texas MD Anderson Cancer Center and Rice University today announced the creation of the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment. Credit: Rice University HOUSTON ― The University of Texas MD Anderson Cancer Center and Rice University today

Researchers have identified a protein called PFDN6 that may play a role in the development and spread of colorectal cancer (CRC). The study, published in [journal name], found that PFDN6 levels are increased in CRC patients and contribute to tumor growth. By reducing PFDN6 in

COLUMBUS, Ohio – Chemotherapy is known to cause behavioral side effects, including cognitive decline. Notably, the gut microbiome communicates with the brain to affect behavior, including cognition. Credit: The Ohio State University Wexner Medical Center COLUMBUS, Ohio – Chemotherapy is known to cause behavioral side